+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Facial Aesthetics Market Size, Share & Industry Trends Analysis Report By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels), By Application, By End User, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 228 Pages
  • August 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5659105
The Global Facial Aesthetics Market size is expected to reach $15.2 billion by 2028, rising at a market growth of 14.5% CAGR during the forecast period.

Facial aesthetics, also known as facial cosmetic surgeries, are non-surgical operations intended to reduce the appearance of age-related changes in the skin. Dermal fillers and Botox injections are the most common type of ailments used in facial aesthetics. They can be applied to practically any part of the body, but the face, neck, and shoulders are where they are most frequently utilized.

Excessive perspiration, pigmentation removal, the treatment of acne, scars, skin tags, and moles, as well as enhancement of vein look, are other conditions that can be addressed with aesthetic procedures. Botulinum toxin is most frequently used to treat wrinkles on the forehead, between the brows, and around the eyes.



Fillers can be applied to the lips, cheeks, nose-to-mouth lines, and below-the-mouth lines, but they can also be used in place of or in addition to botulinum toxin within the same regions of the face. Different kinds and sizes of molecules can be used to treat various conditions, and an evaluation enables surgeons to choose the kind that is best for the patient.

Treatments for facial aesthetics have the potential to offer significant advantages without surgery. Non-surgical cosmetic procedures that draw attention to a patient's characteristics and enhance their natural beauty are included in facial aesthetics. These procedures, which frequently involve the use of Botox or Fillers, aim to smooth out wrinkles and clarify facial features while also reviving and rejuvenating the skin.

Facial aesthetics also make the skin look and feel healthier. Fighting indications of aging, creating facial symmetry, and tightening wrinkled and drooping skin. Both men and women can choose from a variety of facial aesthetic procedures to project an image that increases their self-assurance and comfort with their appearance.

COVID-19 Impact Analysis

The manufacturing and supply chain for the luxury and beauty industries faced a number of hurdles, like lack of timely product delivery to customers and uneven demand for goods and services. The market also witnessed a brief period of negative growth, which can be attributed to a number of factors, including a decline in product demand from major end users, limited operations in the majority of industries, the temporary closure of major end-user facilities (such as beauty salons and spas), a disrupted supply chain, and difficulties in providing necessary/post-sales services because of the lockdown.

Market Growth Factors

Expansion Of The Geriatric Population All Over The World

The quantity and proportion of aging people in the world's populations are growing, which is a global phenomenon known as population aging. According to the United Nations Organization, I n 2019, there was approximately 703 million people worldwide who were 65 or older. In 2050, it is expected that there will be 1.5 billion senior people. In the entire world, the percentage of people 65 and older rose from 6% in 1990 to 9% in 2019. By 2050, the number is estimated to reach 16%, meaning that 1 in 6 individual all over the world is expected to be 65 years of age or older. The majority of the world's population is also witnessing an extended life expectancy.

Surge In The Adoption Due To Minimal Invasion

One of the major factors that are driving the growth of the facial aesthetics market is that it is a very minimally invasive surgery. Among the most popular non-invasive rejuvenation methods, chemical peels, injectable botulinum toxin, and soft-tissue fillers are all useful for improving the appearance of the face. For the diagnosis and treatment of a variety of ailments that formerly required sternotomy or open surgeries, minimally invasive surgery is an excellent strategy.

Market Restraining Factors

Side Effects Of The Toxins Used In Facial Aesthetics

Facial aesthetics has the potential to produce severe adverse effects, despite the fact that it is normally considered to be safe when used within a clinical setting. Most typically, the injection can be injected into the wrong muscle group, or over time, it might spread from the injection site and temporarily paralyze undesirable muscles. The primary cause of the negative effects of cosmetic use is unintentional paralysis of the facial muscles. These include trouble swallowing, weakened muscles, and partial paralysis of the face.

Product Outlook

By Product, the Facial Aesthetics Market is segregated into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. In 2021, the dermal fillers segment acquired the largest revenue share of the facial aesthetics market. The rising growth of the segment is primarily owing to the changing habits and lifestyles of people all over the world. A significant number of people all over the world do smoke regularly.



Application Outlook

On the basis of Application, the Facial Aesthetics Market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. In 2021, the lip enhancement segment registered a substantial revenue share of the facial aesthetics market. The method of lip augmentation that is most frequently utilized nowadays is an injected dermal filler. Dermal fillers come in a variety of forms that can be injected into the lips and the area surrounding the mouth.

End-User Outlook

Based on End-User, the Facial Aesthetics Market is classified into Specialty and Dermatology Clinics, Hospitals, and Others. In 2021, the hospitals segment witnessed the highest revenue share of the facial aesthetics market. Due to an increase in hospitals performing facial aesthetic procedures and rising government spending to upgrade hospital aesthetic centers, the growth of this segment is accelerated.

Regional Outlook

Region-Wise, the Facial Aesthetics Market is analyzed across North America, Europe, Asia-pacific, and LAMEA. In 2021, North America accounted for the largest revenue share of the facial aesthetics market. The surging growth of the regional market is attributed to an increase in botulinum toxin procedures, a rise in the number of facial aesthetics product approvals, the existence of the facial aesthetics industry, and improvements in the medical and aesthetic sectors in the area are all credited with this.

Cardinal Matrix - Facial Aesthetics Market Competition Analysis



The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; AbbVie, Inc. and Johnson & Johnson are the forerunners in the Facial Aesthetics Market. Companies such as Merz Pharma GmbH & Co. KGaA, Galderma S.A. and Candela Medical Corporation are some of the key innovators in Facial Aesthetics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.

Strategies deployed in Facial Aesthetics Market

; Partnerships, Collaborations and Agreements:

  • Mar-2022: Cynosure signed an agreement with Jeisys Medical KK, a subsidiary of Jeisys Medical. Under this agreement, Jeisys Medical is expected to distribute products of the energy-based laser portfolio of Cynosure in Japan. In addition, this agreement is expected to also strengthen the foothold of Cynosure across Japan.
  • Sep-2021: Galderma came into an agreement with Sofregen Medical, a medical device company. With this acquisition, the companies is expected to together conduct co-development activities respective to a novel silk-based bio-stimulator fillers portfolio. Moreover, this agreement is expected to also reinforce Galderma’s commitment to bringing science-based innovation across the market.
  • Aug-2021: Merz Therapeutics partnered with Vensica, a medical device company. Under this partnership, Merz is expected to leverage Vensica’s innovative ultrasound-assisted delivery catheter in order to inject botulinum neurotoxin A into the bladder wall.
  • Jan-2021: Merz Aesthetics teamed up with Candela Medical, an American laser company. Following this collaboration, the companies is expected to work on expanding their product offerings along with complying with the demands of patients for full-spectrum aesthetic care.
  • Jan-2020: Teoxane entered into an agreement with Revance Therapeutics, a biopharmaceutical company. Under this agreement, Revance is expected to commercialize the RHA filler portfolio of Teoxane within the United States.

; Product Launches and Product Expansions:

  • Feb-2022: Merz Aesthetics launched Radiesse Lidocaine injectable implant for deep injection for soft tissue augmentation. With this product launch, the company aimed to mark the first and only calcium hydroxylapatite offerings across the United States. Moreover, Radiesse Lidocaine is also the only injectable treatment approved by the FDA for the improvement of jawline contour.

; Acquisitions and Mergers:

  • Jan-2022: Galderma took over ALASTIN Skincare, a specialty aesthetics company. This acquisition aimed to improve the integrated dermatology platform of Galderma with the addition of a comprehensive range of scientifically-proven solutions for daily skincare regimens.
  • May-2020: AbbVie acquired Allergan, an American global pharmaceutical company. Under this acquisition, the company aimed to leverage growth prospects in neuroscience through the addition of Allergan's Botox therapeutics, Vraylar, and Ubrelvy.

; Approvals and Trials:

  • Jan-2022: Teoxane received the US FDA approval for its RHA Redensity, a gel implant. The new injection aimed to reduce the visibility of wrinkles and lines through its composition of chemical sodium hyaluronic acid, 0.3% of the drug lidocaine hydrochloride, and 1.4-butanediol diglycidyl ether (BDDE) in order to lower injection and pain.
  • Jun-2021: Galderma received the US FDA approval for Restylane Contour to address cheek augmentation as well as midface contour deficiencies in adults with age above 21. The new product aimed to offer a reliable treatment to patients. Although the individual outcome may vary, a majority of Restylane Contour patients were found satisfied with their results.

Scope of the Study

Market Segments Covered in the Report:

By Product

  • Dermal fillers
  • Botulinum toxin
  • Microdermabrasion
  • Chemical peels
  • Others

By Application

  • Facial line correction treatment
  • Scar treatment
  • Lip enhancement
  • Restoration of volume or Fullness
  • Others

By End User

  • Hospitals
  • Specialty & Dermatology Clinics
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • AbbVie, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Galderma S.A.
  • Candela Medical Corporation (Syneron Medical Ltd.)
  • Teoxane S.A.
  • Johnson & Johnson
  • Cynosure, LLC
  • Bausch Health Companies, Inc.
  • Ipsen Pharma Biotech SAS
  • Fotona D.o.o.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Facial Aesthetics Market, by Product
1.4.2 Global Facial Aesthetics Market, by Application
1.4.3 Global Facial Aesthetics Market, by End User
1.4.4 Global Facial Aesthetics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jan - 2022, Mar) Leading Players
Chapter 4. Global Facial Aesthetics Market by Product
4.1 Global Dermal fillers Market by Region
4.2 Global Botulinum toxin Market by Region
4.3 Global Microdermabrasion Market by Region
4.4 Global Chemical peels Market by Region
4.5 Global Others Market by Region
Chapter 5. Global Facial Aesthetics Market by Application
5.1 Global Facial line correction treatment Market by Region
5.2 Global Scar treatment Market by Region
5.3 Global Lip enhancement Market by Region
5.4 Global Restoration of volume or Fullness Market by Region
5.5 Global Others Market by Region
Chapter 6. Global Facial Aesthetics Market by End User
6.1 Global Hospitals Market by Region
6.2 Global Specialty & Dermatology Clinics Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Facial Aesthetics Market by Region
7.1 North America Facial Aesthetics Market
7.1.1 North America Facial Aesthetics Market by Product
7.1.1.1 North America Dermal fillers Market by Country
7.1.1.2 North America Botulinum toxin Market by Country
7.1.1.3 North America Microdermabrasion Market by Country
7.1.1.4 North America Chemical peels Market by Country
7.1.1.5 North America Others Market by Country
7.1.2 North America Facial Aesthetics Market by Application
7.1.2.1 North America Facial line correction treatment Market by Country
7.1.2.2 North America Scar treatment Market by Country
7.1.2.3 North America Lip enhancement Market by Country
7.1.2.4 North America Restoration of volume or Fullness Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Facial Aesthetics Market by End User
7.1.3.1 North America Hospitals Market by Country
7.1.3.2 North America Specialty & Dermatology Clinics Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Facial Aesthetics Market by Country
7.1.4.1 US Facial Aesthetics Market
7.1.4.1.1 US Facial Aesthetics Market by Product
7.1.4.1.2 US Facial Aesthetics Market by Application
7.1.4.1.3 US Facial Aesthetics Market by End User
7.1.4.2 Canada Facial Aesthetics Market
7.1.4.2.1 Canada Facial Aesthetics Market by Product
7.1.4.2.2 Canada Facial Aesthetics Market by Application
7.1.4.2.3 Canada Facial Aesthetics Market by End User
7.1.4.3 Mexico Facial Aesthetics Market
7.1.4.3.1 Mexico Facial Aesthetics Market by Product
7.1.4.3.2 Mexico Facial Aesthetics Market by Application
7.1.4.3.3 Mexico Facial Aesthetics Market by End User
7.1.4.4 Rest of North America Facial Aesthetics Market
7.1.4.4.1 Rest of North America Facial Aesthetics Market by Product
7.1.4.4.2 Rest of North America Facial Aesthetics Market by Application
7.1.4.4.3 Rest of North America Facial Aesthetics Market by End User
7.2 Europe Facial Aesthetics Market
7.2.1 Europe Facial Aesthetics Market by Product
7.2.1.1 Europe Dermal fillers Market by Country
7.2.1.2 Europe Botulinum toxin Market by Country
7.2.1.3 Europe Microdermabrasion Market by Country
7.2.1.4 Europe Chemical peels Market by Country
7.2.1.5 Europe Others Market by Country
7.2.2 Europe Facial Aesthetics Market by Application
7.2.2.1 Europe Facial line correction treatment Market by Country
7.2.2.2 Europe Scar treatment Market by Country
7.2.2.3 Europe Lip enhancement Market by Country
7.2.2.4 Europe Restoration of volume or Fullness Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Facial Aesthetics Market by End User
7.2.3.1 Europe Hospitals Market by Country
7.2.3.2 Europe Specialty & Dermatology Clinics Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Facial Aesthetics Market by Country
7.2.4.1 Germany Facial Aesthetics Market
7.2.4.1.1 Germany Facial Aesthetics Market by Product
7.2.4.1.2 Germany Facial Aesthetics Market by Application
7.2.4.1.3 Germany Facial Aesthetics Market by End User
7.2.4.2 UK Facial Aesthetics Market
7.2.4.2.1 UK Facial Aesthetics Market by Product
7.2.4.2.2 UK Facial Aesthetics Market by Application
7.2.4.2.3 UK Facial Aesthetics Market by End User
7.2.4.3 France Facial Aesthetics Market
7.2.4.3.1 France Facial Aesthetics Market by Product
7.2.4.3.2 France Facial Aesthetics Market by Application
7.2.4.3.3 France Facial Aesthetics Market by End User
7.2.4.4 Russia Facial Aesthetics Market
7.2.4.4.1 Russia Facial Aesthetics Market by Product
7.2.4.4.2 Russia Facial Aesthetics Market by Application
7.2.4.4.3 Russia Facial Aesthetics Market by End User
7.2.4.5 Spain Facial Aesthetics Market
7.2.4.5.1 Spain Facial Aesthetics Market by Product
7.2.4.5.2 Spain Facial Aesthetics Market by Application
7.2.4.5.3 Spain Facial Aesthetics Market by End User
7.2.4.6 Italy Facial Aesthetics Market
7.2.4.6.1 Italy Facial Aesthetics Market by Product
7.2.4.6.2 Italy Facial Aesthetics Market by Application
7.2.4.6.3 Italy Facial Aesthetics Market by End User
7.2.4.7 Rest of Europe Facial Aesthetics Market
7.2.4.7.1 Rest of Europe Facial Aesthetics Market by Product
7.2.4.7.2 Rest of Europe Facial Aesthetics Market by Application
7.2.4.7.3 Rest of Europe Facial Aesthetics Market by End User
7.3 Asia Pacific Facial Aesthetics Market
7.3.1 Asia Pacific Facial Aesthetics Market by Product
7.3.1.1 Asia Pacific Dermal fillers Market by Country
7.3.1.2 Asia Pacific Botulinum toxin Market by Country
7.3.1.3 Asia Pacific Microdermabrasion Market by Country
7.3.1.4 Asia Pacific Chemical peels Market by Country
7.3.1.5 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Facial Aesthetics Market by Application
7.3.2.1 Asia Pacific Facial line correction treatment Market by Country
7.3.2.2 Asia Pacific Scar treatment Market by Country
7.3.2.3 Asia Pacific Lip enhancement Market by Country
7.3.2.4 Asia Pacific Restoration of volume or Fullness Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Facial Aesthetics Market by End User
7.3.3.1 Asia Pacific Hospitals Market by Country
7.3.3.2 Asia Pacific Specialty & Dermatology Clinics Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Facial Aesthetics Market by Country
7.3.4.1 China Facial Aesthetics Market
7.3.4.1.1 China Facial Aesthetics Market by Product
7.3.4.1.2 China Facial Aesthetics Market by Application
7.3.4.1.3 China Facial Aesthetics Market by End User
7.3.4.2 Japan Facial Aesthetics Market
7.3.4.2.1 Japan Facial Aesthetics Market by Product
7.3.4.2.2 Japan Facial Aesthetics Market by Application
7.3.4.2.3 Japan Facial Aesthetics Market by End User
7.3.4.3 India Facial Aesthetics Market
7.3.4.3.1 India Facial Aesthetics Market by Product
7.3.4.3.2 India Facial Aesthetics Market by Application
7.3.4.3.3 India Facial Aesthetics Market by End User
7.3.4.4 South Korea Facial Aesthetics Market
7.3.4.4.1 South Korea Facial Aesthetics Market by Product
7.3.4.4.2 South Korea Facial Aesthetics Market by Application
7.3.4.4.3 South Korea Facial Aesthetics Market by End User
7.3.4.5 Singapore Facial Aesthetics Market
7.3.4.5.1 Singapore Facial Aesthetics Market by Product
7.3.4.5.2 Singapore Facial Aesthetics Market by Application
7.3.4.5.3 Singapore Facial Aesthetics Market by End User
7.3.4.6 Malaysia Facial Aesthetics Market
7.3.4.6.1 Malaysia Facial Aesthetics Market by Product
7.3.4.6.2 Malaysia Facial Aesthetics Market by Application
7.3.4.6.3 Malaysia Facial Aesthetics Market by End User
7.3.4.7 Rest of Asia Pacific Facial Aesthetics Market
7.3.4.7.1 Rest of Asia Pacific Facial Aesthetics Market by Product
7.3.4.7.2 Rest of Asia Pacific Facial Aesthetics Market by Application
7.3.4.7.3 Rest of Asia Pacific Facial Aesthetics Market by End User
7.4 LAMEA Facial Aesthetics Market
7.4.1 LAMEA Facial Aesthetics Market by Product
7.4.1.1 LAMEA Dermal fillers Market by Country
7.4.1.2 LAMEA Botulinum toxin Market by Country
7.4.1.3 LAMEA Microdermabrasion Market by Country
7.4.1.4 LAMEA Chemical peels Market by Country
7.4.1.5 LAMEA Others Market by Country
7.4.2 LAMEA Facial Aesthetics Market by Application
7.4.2.1 LAMEA Facial line correction treatment Market by Country
7.4.2.2 LAMEA Scar treatment Market by Country
7.4.2.3 LAMEA Lip enhancement Market by Country
7.4.2.4 LAMEA Restoration of volume or Fullness Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Facial Aesthetics Market by End User
7.4.3.1 LAMEA Hospitals Market by Country
7.4.3.2 LAMEA Specialty & Dermatology Clinics Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Facial Aesthetics Market by Country
7.4.4.1 Brazil Facial Aesthetics Market
7.4.4.1.1 Brazil Facial Aesthetics Market by Product
7.4.4.1.2 Brazil Facial Aesthetics Market by Application
7.4.4.1.3 Brazil Facial Aesthetics Market by End User
7.4.4.2 Argentina Facial Aesthetics Market
7.4.4.2.1 Argentina Facial Aesthetics Market by Product
7.4.4.2.2 Argentina Facial Aesthetics Market by Application
7.4.4.2.3 Argentina Facial Aesthetics Market by End User
7.4.4.3 UAE Facial Aesthetics Market
7.4.4.3.1 UAE Facial Aesthetics Market by Product
7.4.4.3.2 UAE Facial Aesthetics Market by Application
7.4.4.3.3 UAE Facial Aesthetics Market by End User
7.4.4.4 Saudi Arabia Facial Aesthetics Market
7.4.4.4.1 Saudi Arabia Facial Aesthetics Market by Product
7.4.4.4.2 Saudi Arabia Facial Aesthetics Market by Application
7.4.4.4.3 Saudi Arabia Facial Aesthetics Market by End User
7.4.4.5 South Africa Facial Aesthetics Market
7.4.4.5.1 South Africa Facial Aesthetics Market by Product
7.4.4.5.2 South Africa Facial Aesthetics Market by Application
7.4.4.5.3 South Africa Facial Aesthetics Market by End User
7.4.4.6 Nigeria Facial Aesthetics Market
7.4.4.6.1 Nigeria Facial Aesthetics Market by Product
7.4.4.6.2 Nigeria Facial Aesthetics Market by Application
7.4.4.6.3 Nigeria Facial Aesthetics Market by End User
7.4.4.7 Rest of LAMEA Facial Aesthetics Market
7.4.4.7.1 Rest of LAMEA Facial Aesthetics Market by Product
7.4.4.7.2 Rest of LAMEA Facial Aesthetics Market by Application
7.4.4.7.3 Rest of LAMEA Facial Aesthetics Market by End User
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Acquisition and Mergers:
8.2 Merz Pharma GmbH & Co. KGaA
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.2.2 Product Launches and Product Expansions:
8.3 Galderma S.A.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Approvals and Trials:
8.3.2.3 Acquisition and Mergers:
8.4 Candela Medical Corporation (Syneron Medical Ltd.)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Geographical Expansions:
8.5 Teoxane S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Approvals and Trials:
8.6 Johnson and Johnson
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental &Regional Analysis
8.6.4 Research & Development Expenses
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Ipsen Pharma Biotech SAS
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fotona D.o.o.
8.10.1 Company Overview

Companies Mentioned

  • AbbVie, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Galderma S.A.
  • Candela Medical Corporation (Syneron Medical Ltd.)
  • Teoxane S.A.
  • Johnson & Johnson
  • Cynosure, LLC
  • Bausch Health Companies, Inc.
  • Ipsen Pharma Biotech SAS
  • Fotona D.o.o.

Methodology

Loading
LOADING...